Stock listing
A1180P Stock Price, News, Filings & Events — Ocular Therapeutix, Inc.
Selected listing: A1180P · LS · EUR · DE
This page tracks Ocular Therapeutix, Inc.'s A1180P:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1180P:LS. A1180P:LS is the stock-level entry point for investors researching Ocular Therapeutix, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A1180P:LS
- Asset type
- Stock
- Market cap
- $2.28B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Ocular Therapeutix, Inc. A1180P:LS stock context
This page tracks Ocular Therapeutix, Inc.'s A1180P:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A1180P:LS. A1180P:LS is the stock-level entry point for investors researching Ocular Therapeutix, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Ocular Therapeutix, Inc.
Ocular Therapeutix : trade; Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 13, 2026
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emergin...
August 10, 2026
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
August 3, 2026
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
June 17, 2026
Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease
June 9, 2026
Ocular Therapeutix, Inc. earnings calls
Ocular Therapeutix, Inc. (OCUL) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Ocular Therapeutix, Inc. (OCUL) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Ocular Therapeutix, Inc. (OCUL) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Ocular Therapeutix, Inc. (OCUL) Q4 2024 Earnings Call
March 3, 2025 · Replay with transcript and chapters
Ocular Therapeutix, Inc. (OCUL) Q3 2024 Earnings Call
November 14, 2024 · Replay with transcript and chapters
Ocular Therapeutix, Inc. (OCUL) Q2 2024 Earnings Call
August 7, 2024 · Replay with transcript and chapters
Research Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. investor report
Review AI stock analysis and investor report context for A1180P:LS.
Ocular Therapeutix, Inc. company profile
View the public company page for Ocular Therapeutix, Inc. on 6ix.
Ocular Therapeutix, Inc. news
Read company news and market updates connected to Ocular Therapeutix, Inc..
Ocular Therapeutix, Inc. investor events
Find investor webinars, events, and replay context for Ocular Therapeutix, Inc..
Alternate listings
OCUL:NASDAQ
US · USD
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
A1180P:LSX
DE · EUR
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
0OT:GETTEX
DE · EUR
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
0OT:TRADEGATE
DE · EUR
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
OCUL:BOATS
US · USD
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
0OT:BX
CH · CHF
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
0OT:DUS
DE · EUR
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
0OT:FWB
DE · EUR
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
0OT:HAM
DE · EUR
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.
0OT:SWB
DE · EUR
Alternate listing for Ocular Therapeutix, Inc.; the primary context on this page is A1180P:LS.